Director Aaron Mendelsohn filed a Form 4 with the SEC on November 19, 2026, disclosing a private purchase of 99,010 shares of Vivani Medical, Inc. common stock on November 18, 2026.

Key Highlights

  • Transaction: Aaron Mendelsohn, a director of Vivani Medical, Inc. (NASDAQ:VANI), acquired 99,010 shares of common stock on November 18, 2026.
  • Price per share: The shares were purchased at $1.01 each, described in the filing as the last reported sale price of the issuer's common stock on Nasdaq on November 13, 2026.
  • Gross proceeds: According to the filing, the gross proceeds from the private sale transaction were $100,000.10.
  • Transaction type: The purchase was made in a private sale transaction pursuant to a Share Purchase Agreement dated November 15, 2026.
  • Post-transaction indirect ownership: Following the transaction, Mendelsohn indirectly holds 997,327 shares, plus 168,170 shares held directly.
  • Total beneficial ownership: The filing reports Mendelsohn owns 1,165,497 shares directly and/or indirectly across multiple holding structures.

Aaron Mendelsohn's Private Share Purchase and Ownership Structure at Vivani Medical

According to the Form 4 filed on November 19, 2026, Aaron Mendelsohn, a director of Vivani Medical, Inc. (NASDAQ:VANI), purchased 99,010 shares of the company's common stock in a private sale transaction. The filing states the purchase price of $1.01 per share corresponded to the last reported sale price of the issuer's common stock on Nasdaq on November 13, 2026, the trading day immediately prior to the Share Purchase Agreement date of November 15, 2026. The filing reports gross proceeds from the transaction of $100,000.10.

The filing discloses that following the reported transaction, Mendelsohn indirectly beneficially owns 997,327 shares, with 168,170 shares held directly. The filing further details that Mendelsohn's total beneficial ownership of 1,165,497 shares is composed of three components: 168,170 shares owned directly by the reporting person; 150,930 shares held across five trusts established for separate grandchildren of Mendelsohn, each trust owning 30,186 shares, over which Mendelsohn holds voting and dispositive authority; and 846,397 shares owned by MFE, LLC, over which Mendelsohn also holds voting and dispositive authority.

The filing notes that Mendelsohn disclaims pecuniary interest in 20% of MFE, LLC, and therefore disclaims beneficial ownership of 169,279 of the 846,397 shares held by that entity, which the filing states "are beneficially owned by other members of the limited liability company." The Form 4 was signed by Anthony Baldor as attorney-in-fact on November 19, 2026.

What Was Disclosed

Director Aaron Mendelsohn reported a private purchase of 99,010 Vivani Medical common shares at $1.01 per share on November 18, 2026, for gross proceeds of $100,000.10, bringing his total reported beneficial ownership to 1,165,497 shares held through direct and indirect structures.